Ketamine Treatment Market, Global Outlook and Forecast 2022-2028

August 2022 | 63 pages | ID: K7B3BC1F3B97EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Ketamine Treatment in Global, including the following market information:

Global Ketamine Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Ketamine Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Ketamine Treatment include Save Minds UK, Arevipharma GmbH, Core One Labs, Johnson & Johnson, Mindbloom, Ember, UQUIFA, Pfizer and Biotechnica Pharma Global (BPG). etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Ketamine Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Ketamine Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Ketamine Treatment Market Segment Percentages, by Type, 2021 (%)

• Injection
• Powder

Global Ketamine Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Ketamine Treatment Market Segment Percentages, by Application, 2021 (%)

• Anesthesia
• Pain
• Depression
• Seizures

Global Ketamine Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Ketamine Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Ketamine Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Ketamine Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Save Minds UK
• Arevipharma GmbH
• Core One Labs
• Johnson & Johnson
• Mindbloom
• Ember
• UQUIFA
• Pfizer
• Biotechnica Pharma Global (BPG)

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Ketamine Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Ketamine Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL KETAMINE TREATMENT OVERALL MARKET SIZE

2.1 Global Ketamine Treatment Market Size: 2021 VS 2028
2.2 Global Ketamine Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Ketamine Treatment Players in Global Market
3.2 Top Global Ketamine Treatment Companies Ranked by Revenue
3.3 Global Ketamine Treatment Revenue by Companies
3.4 Top 3 and Top 5 Ketamine Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Ketamine Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Ketamine Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Ketamine Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Ketamine Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Ketamine Treatment Market Size Markets, 2021 & 2028
  4.1.2 Injection
  4.1.3 Powder
4.2 By Type - Global Ketamine Treatment Revenue & Forecasts
  4.2.1 By Type - Global Ketamine Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Ketamine Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Ketamine Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Ketamine Treatment Market Size, 2021 & 2028
  5.1.2 Anesthesia
  5.1.3 Pain
  5.1.4 Depression
  5.1.5 Seizures
5.2 By Application - Global Ketamine Treatment Revenue & Forecasts
  5.2.1 By Application - Global Ketamine Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Ketamine Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Ketamine Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Ketamine Treatment Market Size, 2021 & 2028
6.2 By Region - Global Ketamine Treatment Revenue & Forecasts
  6.2.1 By Region - Global Ketamine Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Ketamine Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Ketamine Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Ketamine Treatment Revenue, 2017-2028
  6.3.2 US Ketamine Treatment Market Size, 2017-2028
  6.3.3 Canada Ketamine Treatment Market Size, 2017-2028
  6.3.4 Mexico Ketamine Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Ketamine Treatment Revenue, 2017-2028
  6.4.2 Germany Ketamine Treatment Market Size, 2017-2028
  6.4.3 France Ketamine Treatment Market Size, 2017-2028
  6.4.4 U.K. Ketamine Treatment Market Size, 2017-2028
  6.4.5 Italy Ketamine Treatment Market Size, 2017-2028
  6.4.6 Russia Ketamine Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Ketamine Treatment Market Size, 2017-2028
  6.4.8 Benelux Ketamine Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Ketamine Treatment Revenue, 2017-2028
  6.5.2 China Ketamine Treatment Market Size, 2017-2028
  6.5.3 Japan Ketamine Treatment Market Size, 2017-2028
  6.5.4 South Korea Ketamine Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Ketamine Treatment Market Size, 2017-2028
  6.5.6 India Ketamine Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Ketamine Treatment Revenue, 2017-2028
  6.6.2 Brazil Ketamine Treatment Market Size, 2017-2028
  6.6.3 Argentina Ketamine Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Ketamine Treatment Revenue, 2017-2028
  6.7.2 Turkey Ketamine Treatment Market Size, 2017-2028
  6.7.3 Israel Ketamine Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Ketamine Treatment Market Size, 2017-2028
  6.7.5 UAE Ketamine Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Save Minds UK
  7.1.1 Save Minds UK Corporate Summary
  7.1.2 Save Minds UK Business Overview
  7.1.3 Save Minds UK Ketamine Treatment Major Product Offerings
  7.1.4 Save Minds UK Ketamine Treatment Revenue in Global Market (2017-2022)
  7.1.5 Save Minds UK Key News
7.2 Arevipharma GmbH
  7.2.1 Arevipharma GmbH Corporate Summary
  7.2.2 Arevipharma GmbH Business Overview
  7.2.3 Arevipharma GmbH Ketamine Treatment Major Product Offerings
  7.2.4 Arevipharma GmbH Ketamine Treatment Revenue in Global Market (2017-2022)
  7.2.5 Arevipharma GmbH Key News
7.3 Core One Labs
  7.3.1 Core One Labs Corporate Summary
  7.3.2 Core One Labs Business Overview
  7.3.3 Core One Labs Ketamine Treatment Major Product Offerings
  7.3.4 Core One Labs Ketamine Treatment Revenue in Global Market (2017-2022)
  7.3.5 Core One Labs Key News
7.4 Johnson & Johnson
  7.4.1 Johnson & Johnson Corporate Summary
  7.4.2 Johnson & Johnson Business Overview
  7.4.3 Johnson & Johnson Ketamine Treatment Major Product Offerings
  7.4.4 Johnson & Johnson Ketamine Treatment Revenue in Global Market (2017-2022)
  7.4.5 Johnson & Johnson Key News
7.5 Mindbloom
  7.5.1 Mindbloom Corporate Summary
  7.5.2 Mindbloom Business Overview
  7.5.3 Mindbloom Ketamine Treatment Major Product Offerings
  7.5.4 Mindbloom Ketamine Treatment Revenue in Global Market (2017-2022)
  7.5.5 Mindbloom Key News
7.6 Ember
  7.6.1 Ember Corporate Summary
  7.6.2 Ember Business Overview
  7.6.3 Ember Ketamine Treatment Major Product Offerings
  7.6.4 Ember Ketamine Treatment Revenue in Global Market (2017-2022)
  7.6.5 Ember Key News
7.7 UQUIFA
  7.7.1 UQUIFA Corporate Summary
  7.7.2 UQUIFA Business Overview
  7.7.3 UQUIFA Ketamine Treatment Major Product Offerings
  7.7.4 UQUIFA Ketamine Treatment Revenue in Global Market (2017-2022)
  7.7.5 UQUIFA Key News
7.8 Pfizer
  7.8.1 Pfizer Corporate Summary
  7.8.2 Pfizer Business Overview
  7.8.3 Pfizer Ketamine Treatment Major Product Offerings
  7.8.4 Pfizer Ketamine Treatment Revenue in Global Market (2017-2022)
  7.8.5 Pfizer Key News
7.9 Biotechnica Pharma Global (BPG)
  7.9.1 Biotechnica Pharma Global (BPG) Corporate Summary
  7.9.2 Biotechnica Pharma Global (BPG) Business Overview
  7.9.3 Biotechnica Pharma Global (BPG) Ketamine Treatment Major Product Offerings
  7.9.4 Biotechnica Pharma Global (BPG) Ketamine Treatment Revenue in Global Market (2017-2022)
  7.9.5 Biotechnica Pharma Global (BPG) Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Ketamine Treatment Market Opportunities & Trends in Global Market
Table 2. Ketamine Treatment Market Drivers in Global Market
Table 3. Ketamine Treatment Market Restraints in Global Market
Table 4. Key Players of Ketamine Treatment in Global Market
Table 5. Top Ketamine Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Ketamine Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Ketamine Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Ketamine Treatment Product Type
Table 9. List of Global Tier 1 Ketamine Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Ketamine Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Ketamine Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Ketamine Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Ketamine Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Ketamine Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Ketamine Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Ketamine Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Ketamine Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Ketamine Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Ketamine Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Ketamine Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Ketamine Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Ketamine Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Ketamine Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Ketamine Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Ketamine Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Ketamine Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Ketamine Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Ketamine Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Ketamine Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Save Minds UK Corporate Summary
Table 31. Save Minds UK Ketamine Treatment Product Offerings
Table 32. Save Minds UK Ketamine Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Arevipharma GmbH Corporate Summary
Table 34. Arevipharma GmbH Ketamine Treatment Product Offerings
Table 35. Arevipharma GmbH Ketamine Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Core One Labs Corporate Summary
Table 37. Core One Labs Ketamine Treatment Product Offerings
Table 38. Core One Labs Ketamine Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Johnson & Johnson Corporate Summary
Table 40. Johnson & Johnson Ketamine Treatment Product Offerings
Table 41. Johnson & Johnson Ketamine Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Mindbloom Corporate Summary
Table 43. Mindbloom Ketamine Treatment Product Offerings
Table 44. Mindbloom Ketamine Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Ember Corporate Summary
Table 46. Ember Ketamine Treatment Product Offerings
Table 47. Ember Ketamine Treatment Revenue (US$, Mn), (2017-2022)
Table 48. UQUIFA Corporate Summary
Table 49. UQUIFA Ketamine Treatment Product Offerings
Table 50. UQUIFA Ketamine Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Pfizer Corporate Summary
Table 52. Pfizer Ketamine Treatment Product Offerings
Table 53. Pfizer Ketamine Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Biotechnica Pharma Global (BPG) Corporate Summary
Table 55. Biotechnica Pharma Global (BPG) Ketamine Treatment Product Offerings
Table 56. Biotechnica Pharma Global (BPG) Ketamine Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Ketamine Treatment Segment by Type in 2021
Figure 2. Ketamine Treatment Segment by Application in 2021
Figure 3. Global Ketamine Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Ketamine Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Ketamine Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Ketamine Treatment Revenue in 2021
Figure 8. By Type - Global Ketamine Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Ketamine Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Ketamine Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Ketamine Treatment Revenue Market Share, 2017-2028
Figure 12. US Ketamine Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Ketamine Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Ketamine Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Ketamine Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Ketamine Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Ketamine Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Ketamine Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Ketamine Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Ketamine Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Ketamine Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Ketamine Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Ketamine Treatment Revenue Market Share, 2017-2028
Figure 24. China Ketamine Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Ketamine Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Ketamine Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Ketamine Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Ketamine Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Ketamine Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Ketamine Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Ketamine Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Ketamine Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Ketamine Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Ketamine Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Ketamine Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Ketamine Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Save Minds UK Ketamine Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Arevipharma GmbH Ketamine Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Core One Labs Ketamine Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Johnson & Johnson Ketamine Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Mindbloom Ketamine Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Ember Ketamine Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. UQUIFA Ketamine Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Pfizer Ketamine Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Biotechnica Pharma Global (BPG) Ketamine Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)